The Oncology Research Information Exchange Network and M2Gen formed a bioinformatics collaboration with Celgene Corp.
The partnership, announced April 7, is called the ORIEN Avatar Research Program. The initiative is managed by M2Gen and is designed to generate large amounts of genetic and clinical information on patients consenting to the Total Cancer Care Protocol, a standard operating protocol used by ORIEN member institutions.
Celgene will serve as the founding industry member of a network of participants joining the program, which will have a subscription service for pharmaceutical companies.